Latest Insider Transactions at Tyra Biosciences, Inc. (TYRA)
This section provides a real-time view of insider transactions for Tyra Biosciences, Inc. (TYRA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Tyra Biosciences, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Tyra Biosciences, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 25
2024
|
Nina S Kjellson |
SELL
Open market or private sale
|
Indirect |
5,272
-0.13%
|
$84,352
$16.84 P/Share
|
|
Nov 08
2024
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
1,220,681
+12.31%
|
$19,530,896
$16.25 P/Share
|
|
Nov 07
2024
|
Nina S Kjellson |
SELL
Open market or private sale
|
Indirect |
22,091
-0.53%
|
$375,547
$17.32 P/Share
|
|
Nov 06
2024
|
Nina S Kjellson |
SELL
Open market or private sale
|
Indirect |
52,491
-1.23%
|
$892,347
$17.18 P/Share
|
|
Nov 05
2024
|
Nina S Kjellson |
SELL
Open market or private sale
|
Indirect |
10,493
-0.25%
|
$167,888
$16.77 P/Share
|
|
Nov 04
2024
|
Nina S Kjellson |
SELL
Open market or private sale
|
Indirect |
1,076
-0.03%
|
$18,292
$17.01 P/Share
|
|
Nov 01
2024
|
Nina S Kjellson |
SELL
Open market or private sale
|
Indirect |
26,889
-0.42%
|
$430,224
$16.75 P/Share
|
|
Nov 01
2024
|
Nina S Kjellson |
SELL
Open market or private sale
|
Indirect |
604
-0.02%
|
$10,268
$17.16 P/Share
|
|
Oct 31
2024
|
Nina S Kjellson |
SELL
Open market or private sale
|
Indirect |
100,140
-2.28%
|
$1,602,240
$16.46 P/Share
|
|
Oct 30
2024
|
Nina S Kjellson |
SELL
Open market or private sale
|
Indirect |
11,078
-0.25%
|
$177,248
$16.17 P/Share
|
|
Oct 30
2024
|
Alan Fuhrman Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
9,500
+42.51%
|
$152,000
$16.0 P/Share
|
|
Oct 21
2024
|
Todd Harris President and CEO |
SELL
Open market or private sale
|
Direct |
19,084
-0.7%
|
$515,268
$27.74 P/Share
|
|
Oct 18
2024
|
Boxer Capital Management, LLC |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
2,000,000
-31.02%
|
-
|
|
Oct 18
2024
|
Todd Harris President and CEO |
SELL
Open market or private sale
|
Direct |
43,636
-3.08%
|
$1,178,172
$27.01 P/Share
|
|
Oct 18
2024
|
Ra Capital Management, L.P. |
SELL
Other acquisition or disposition
|
Indirect |
1,000,000
-11.8%
|
-
|
|
Oct 17
2024
|
Todd Harris President and CEO |
SELL
Open market or private sale
|
Direct |
15,394
-0.54%
|
$400,244
$26.11 P/Share
|
|
Oct 16
2024
|
Todd Harris President and CEO |
SELL
Open market or private sale
|
Direct |
33,297
-0.76%
|
$865,722
$26.14 P/Share
|
|
Oct 15
2024
|
Todd Harris President and CEO |
SELL
Open market or private sale
|
Direct |
10,035
-0.68%
|
$240,840
$24.31 P/Share
|
|
Sep 30
2024
|
Todd Harris President and CEO |
SELL
Open market or private sale
|
Direct |
500
-0.03%
|
$12,000
$24.0 P/Share
|
|
Sep 25
2024
|
Todd Harris President and CEO |
SELL
Open market or private sale
|
Direct |
600
-0.04%
|
$14,400
$24.01 P/Share
|
|
Sep 24
2024
|
Todd Harris President and CEO |
SELL
Open market or private sale
|
Direct |
1,055
-0.07%
|
$25,320
$24.02 P/Share
|
|
Sep 23
2024
|
Todd Harris President and CEO |
SELL
Open market or private sale
|
Direct |
10,092
-0.68%
|
$242,208
$24.13 P/Share
|
|
Sep 20
2024
|
Todd Harris President and CEO |
SELL
Open market or private sale
|
Direct |
7,109
-0.48%
|
$170,616
$24.19 P/Share
|
|
Sep 19
2024
|
Todd Harris President and CEO |
SELL
Open market or private sale
|
Direct |
5,698
-0.19%
|
$136,752
$24.7 P/Share
|
|
Sep 18
2024
|
Todd Harris President and CEO |
SELL
Open market or private sale
|
Direct |
3,500
-0.23%
|
$84,000
$24.0 P/Share
|
|
Sep 13
2024
|
Todd Harris President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,350
+0.09%
|
$8,100
$6.58 P/Share
|
|
Sep 13
2024
|
Alan Fuhrman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
954
+22.17%
|
$11,448
$12.48 P/Share
|
|
Jun 13
2024
|
Gilla Kaplan |
BUY
Exercise of conversion of derivative security
|
Direct |
61,392
+40.65%
|
$0
$0.61 P/Share
|
|
Jun 10
2024
|
Daniel Bensen Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,502
-0.81%
|
$70,040
$20.0 P/Share
|
|
Jun 07
2024
|
Daniel Bensen Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
200
-0.05%
|
$4,000
$20.0 P/Share
|
|
Mar 15
2024
|
Alan Fuhrman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
932
+28.01%
|
$11,184
$12.48 P/Share
|
|
Mar 15
2024
|
Hiroomi Tada Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,968
+2.23%
|
$11,808
$6.58 P/Share
|
|
Mar 15
2024
|
Todd Harris President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,880
+0.12%
|
$11,280
$6.58 P/Share
|
|
Mar 11
2024
|
Daniel Bensen Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
200
-0.05%
|
$4,000
$20.0 P/Share
|
|
Mar 07
2024
|
Daniel Bensen Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
68
-0.02%
|
$1,360
$20.0 P/Share
|
|
Mar 06
2024
|
Daniel Bensen Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,733
-0.4%
|
$34,660
$20.09 P/Share
|
|
Mar 05
2024
|
Daniel Bensen Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,189
-0.27%
|
$23,780
$20.02 P/Share
|
|
Mar 04
2024
|
Daniel Bensen Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,063
-1.15%
|
$101,260
$20.08 P/Share
|
|
Mar 01
2024
|
Daniel Bensen Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,900
-0.65%
|
$58,000
$20.04 P/Share
|
|
Feb 29
2024
|
Daniel Bensen Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,050
-0.46%
|
$41,000
$20.0 P/Share
|
|
Feb 28
2024
|
Daniel Bensen Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,849
-1.3%
|
$116,980
$20.13 P/Share
|
|
Feb 27
2024
|
Daniel Bensen Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
745
-0.17%
|
$14,900
$20.0 P/Share
|
|
Feb 12
2024
|
Daniel Bensen Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,501
-0.33%
|
$30,020
$20.0 P/Share
|
|
Feb 07
2024
|
Daniel Bensen Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
9,587
-2.07%
|
$172,566
$18.09 P/Share
|
|
Feb 06
2024
|
Ra Capital Management, L.P. |
BUY
Grant, award, or other acquisition
|
Indirect |
3,180,155
+27.28%
|
$41,342,015
$13.01 P/Share
|
|
Feb 06
2024
|
Boxer Capital, LLC |
BUY
Grant, award, or other acquisition
|
Indirect |
63,412
+42.46%
|
$824,356
$13.01 P/Share
|
|
Feb 06
2024
|
Daniel Bensen Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
15,413
-3.22%
|
$277,434
$18.09 P/Share
|
|
Feb 05
2024
|
Todd Harris President and CEO |
SELL
Open market or private sale
|
Direct |
13,817
-0.91%
|
$221,072
$16.97 P/Share
|
|
Feb 02
2024
|
Todd Harris President and CEO |
SELL
Open market or private sale
|
Direct |
86,183
-2.7%
|
$1,378,928
$16.75 P/Share
|
|
Feb 02
2024
|
Daniel Bensen Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
75,393
-6.84%
|
$1,206,288
$16.68 P/Share
|